echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Audit Office: more than 60 randomly selected drug distribution enterprises suspected of tax evasion of more than 6 billion yuan

    Audit Office: more than 60 randomly selected drug distribution enterprises suspected of tax evasion of more than 6 billion yuan

    • Last Update: 2015-06-29
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: saibelan and financial circles on June 28, 2015, at the 15th meeting of the Standing Committee of the 12th National People's Congress, Liu Jiayi, auditor general of the audit office, made the report of the State Council on 2014 In the annual audit report on the implementation of the central budget and other financial revenues and expenditures (hereinafter referred to as the audit report), drug enterprises' tax evasion and tax evasion and false issuance of VAT invoices are highlighted Audit report: more than 6 billion tax evasions by 65 pharmaceutical companies pointed out in the audit report that the supervision of invoices is not strict, and tax evasion in the field of drug purchase and sale is still prominent Over 20 billion yuan of drug sales invoices and over 6 billion yuan of tax evasion were falsely issued by 65 enterprises in the spot check 36 of them have never been inspected by the tax authorities, and 29 other enterprises have not been inspected in place Some enterprises are special invoicing companies, such as Zhou Zongwu of Heishan County, Liaoning Province, who repeatedly cancelled and opened six enterprises in the same place with less than 50 square meters in two years, suspected of falsely issuing more than 3 billion yuan of special VAT invoices to more than 100 pharmaceutical enterprises In the interpretation of the audit report on the implementation of the 2014 central budget and other financial revenues and expenditures issued on the same day, the Audit Office interpreted the key issues in the form of questions and answers Among them, with regard to the tax issues of pharmaceutical enterprises, the problem is that "the audit report highlights the tax collection and payment in the financial management audit, especially the tax evasion of pharmaceutical distribution enterprises by falsely issuing invoices Please talk about this aspect." Originally for the purpose of tax, the next step is to focus on monitoring the audit office It is of great significance to strengthen the collection and management of tax according to law, ensure the full collection of receivables and prevent excessive collection under the current situation of tense financial balance We have strengthened our audit in this regard, and reflected in the audit report the problems such as tax loss caused by lax tax collection and management and inadequate invoice supervision, and non tax income not collected in full and on time In particular, in view of the hot issues of "difficult and expensive medical treatment" and high social reflection of drug prices, the audit of pharmaceutical purchase and sale enterprises has been strengthened From the audit situation, some drug distribution enterprises still use false invoices to evade taxes Since 2010, the audit office has revealed the clues of false invoices issued by many pharmaceutical enterprises such as GlaxoSmithKline In order to further master the management and use of VAT invoices of pharmaceutical enterprises and prevent the loss of state tax, this year, we focused on the spot check of the use of VAT invoices of more than 60 pharmaceutical distribution enterprises, and found that more than 20 billion yuan of pharmaceutical sales invoices were falsely issued, more than 6 billion yuan of tax evasion was suspected, and some enterprises were special invoicing companies; at the same time, the tax authorities made 36 Twenty nine enterprises have never been inspected, and the inspection of other 29 enterprises is not in place We hope that through the revelation of these problems, we can strengthen the monitoring and analysis of drug distribution enterprises, further improve the value-added tax collection and management system, and strengthen the tax inspection in key areas Some time ago, sepilan had paid close attention to the tax upgrading in Shandong, Henan, Heilongjiang, Shaanxi and other places The pharmaceutical companies suffered a cold winter, and the ticketing business was limited to the news of stagnation Audit strictly checks tax evasion and tax evasion, which is a knife in the head of the tax department In the current situation of continuous tightening of the financial future, the tax strict check on the circulation of medicine will only become more and more strict According to the audit report, 65 drug dealers evaded tax by more than 6 billion yuan, and this one nearly evaded tax by 100 million yuan Think about it According to the statistics of the drug administration, as of 2013, there are 149 thousand wholesale enterprises in China Some people say that most of them have had ticket business Even if it is 50% extreme, it is tens of millions of taxes every year When the state wants to collect more taxes, it aims at kickbacks, but the ticket passing that leads to tax loss is bound to face a cold winter The end of the ticket passing era is not alarmist See http://www.xygpl.com/contents/3/8575.html
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.